We’re Here for You

PADCEV Support SolutionsSM is designed to be the single point of contact for patients prescribed PADCEV® (enfortumab vedotin-ejfv) to address questions about insurance coverage or accessing PADCEV.a We’re here to answer your questions!

To speak with a dedicated access specialist, please call us at 1-888-402-0627, Monday–Friday, 8:30 AM–8:00 PM ET.

The PADCEV Copay Assistance Programb is for eligible patients who have private commercial health insurance and are not insured by any federal or state healthcare program, including, but not limited to, Medicare, Medicaid, TRICARE, or Veterans Affairs (VA). Under this program:

  • Patients may pay as little as $5 per dose
  • A patient will be enrolled in the program for a 12-month period
  • Annual maximum copay assistance limit of $25,000 per calendar year
  • There are no income requirements

Enrolling in the PADCEV Copay Assistance Program

PADCEV Support Solutions can enroll you in the PADCEV Copay Assistance Program.

For more information, contact PADCEV Support Solutions at 1-888-402-0627, Monday–Friday, 8:30 AM–8:00 PM ET.

The PADCEV Patient Assistance Programc (PAP) provides PADCEV at no cost to uninsured patients who meet the program eligibility requirements.

Eligibility Requirements

PADCEV Support Solutions can evaluate whether you are eligible for the PAP.

You may be eligible for the PADCEV Patient Assistance Program if you:

  • Do not have insurance or have insurance that does not cover PADCEV,
  • Have a verifiable shipping address within the United States,
  • Have been prescribed PADCEV for an FDA-approved indication, AND
  • Meet the program financial eligibility requirements

Application Process

Your healthcare provider can start the application process by submitting the PAP application, which includes the necessary information so that PADCEV Support Solutions can assess your eligibility for the PAP.

Once you are approved for the PADCEV Patient Assistance Program, we will notify both you and your healthcare provider that you have been enrolled. PADCEV will then be shipped directly to your healthcare provider.

For more information, contact us at 1-888-402-0627, Monday–Friday, 8:30 AM–8:00 PM ET.

PADCEV Support Solutions, through the Patient Connect program, offers additional patient and caregiver support to people like you who have been prescribed PADCEV. This support helps connect you and your loved ones to educational resources and support based on your particular needs to help you manage your disease and daily life while on treatment.


When you call PADCEV Support Solutions, a trained representative will speak with you to understand the types of challenges you may be facing and will conduct a search of various independent local and national organizationsd that provide support and resources that may be helpful for you and your loved ones.

Patient Connect resources may include:

Emotional Support

  • Social workers, counseling services, or online communities for patients
  • Emotional support for your family members and friends

Logistical Support

  • Transportation and lodging assistance related to treatment
  • Help with other day-to-day tasks

Informational Support

  • Other educational resources about your disease and treatment
  • Information on nutrition and self-care

Call PADCEV Support Solutions at 1-888-402-0627, Monday–Friday, 8:30 AM–8:00 PM ET to learn about potential resources that may be available.

aPADCEV Support Solutions is a component of Astellas Pharma Support SolutionsSM.

bBy enrolling in the PADCEV Copay Assistance Program ("Program"), the patient acknowledges that they currently meet the eligibility criteria and will comply with the following terms and conditions: The Program is for eligible patients with commercial prescription insurance for PADCEV® (enfortumab vedotin-ejfv) and is good for use only with a valid prescription for PADCEV. The Program has an annual maximum copay assistance limit of $25,000 per calendar year. After the annual maximum on copay assistance is reached, patient will be responsible for the remaining out-of-pocket costs for PADCEV. The Program is not valid for patients insured by any state or federal healthcare program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Patients who move from commercial insurance to federal or state prescription health insurance will no longer be eligible, and agree to notify the Program of any such change. This offer is not valid for cash paying patients. Patients agree not to seek reimbursement from any health insurance or third party for all or any part of the benefit received by the patient through the Program. This offer is not conditioned on any past, present, or future purchase of PADCEV. This offer is not transferrable, has no cash value, and cannot be combined with any other offer, free trial, prescription savings card, or discount. The full value of the Program benefits is intended to pass entirely to the eligible patient. The benefit available under this Program is valid only for the patient's out-of-pocket medication costs for PADCEV. The benefit is not valid for any other out-of-pocket costs such as medication administration charges or other healthcare provider services. No other individual or entity (including, without limitation, third party payers, pharmacy benefit managers, or the agents of either) is entitled to receive any benefit, discount, or other amount in connection with this Program. This offer is not health insurance and is only valid for patients in the 50 United States, Washington DC, and Puerto Rico. This Program is void where prohibited by law. No membership fees. Certain rules and restrictions apply. Astellas reserves the right to revoke, rescind, or amend this offer without notice for any reason (including to ensure that the offer is utilized solely for the patient's benefit).

cSubject to eligibility criteria. Terms and conditions apply. Void where prohibited by law.

dSupport is provided through third-party organizations that operate independently and are not controlled or endorsed by Astellas or Pfizer. Availability of support and eligibility requirements are determined by these organizations.

PADCEV® is a registered trademark of Astellas US LLC.